Starting Antiretroviral Treatment Early Improves Outcomes for HIV-Infected Individuals

A major international randomized clinical trial has found that HIV-infected individuals have a considerably lower risk of developing AIDS or other serious illnesses if they start taking antiretroviral drugs sooner, when their CD4+ T-cell count—a key measure of immune system health—is higher, instead of waiting until the CD4+ cell count drops to lower levels. Together […]
Source: Biosingularity - Category: Research Authors: Tags: Biotechnology Source Type: blogs